Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1029
http://purl.obolibrary.org/obo/NCIT_C1029
|
|---|---|
| Preferred Name | Buthionine Sulfoximine |
| Definitions |
A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity. (NCI04) |
|---|---|
| prefLabel | Buthionine Sulfoximine
|
| label | Buthionine Sulfoximine
|
| PDQ_Closed_Trial_Search_ID | 39123
|
| code | C1029
|
| prefixIRI | NCIT:C1029
|
| in_subset |
See more
See less
|
| Display_Name | Buthionine Sulfoximine
|
| Preferred_Name | Buthionine Sulfoximine
|
| FDA_UNII_Code | EEY8DZS103
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C8H18N2O3S
|
| Maps_To | Buthionine Sulfoximine
|
| CAS_Registry | 83730-53-4
|
| NSC Number | 326231
|
| NCI_Drug_Dictionary_ID | 39123
|
| Legacy Concept Name | Buthionine_Sulfoximine
|
| type | |
| ALT_DEFINITION | A drug that may help prevent resistance to some anticancer drugs.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39123
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0054252
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |